Safety of Autologous Umbilical Cord Blood Therapy for Acquired Sensorineural Hearing Loss in Children (open access)

Safety of Autologous Umbilical Cord Blood Therapy for Acquired Sensorineural Hearing Loss in Children

This article presents the results of a phase 1 clinical trial to evaluate the intravenous administration of human umbilical cord blood (hUCB) mononuclear fraction in infants and children with acquired sensorineural hearing loss (SNHL).
Date: June 18, 2018
Creator: Baumgartner, Linda S.; Moore, Ernest J.; Shook, David; Messina, Steven; Day, Mary Clare; Green, Jennifer et al.
System: The UNT Digital Library